Current price: A$2.9
Rejected offer: A$3.25
Upside: 11%+
This is a quick write up about a potentially interesting situation in Australia.
Australian healthcare company Healius (PHCRF) (previously - Primary Health Care) has received a takeover offer priced at A$3.25/share from their largest shareholder (holds 16%) Chinese curtain wall maker Jangho Group (601886.SS). In only 4 days it was rejected and called “opportunistic and undervaluing.” The potential play here is that Jangho, which is currently diversifying into the Australian and Chinese healthcare sector, will raise the bid; however, even if that does